••
Ghana’s healthcare system is facing a significant challenge as Candida infections, particularly Candida albicans, show an alarming rise in resistance to conventional antifungal treatments. Research from the University of Health and Allied Sciences (UHAS) in Ho indicates that 70% of Candida isolates are now resistant to fluconazole, a common antifungal drug. This growing resistance represents a major threat to public health, especially for immunocompromised patients who rely on these medications for survival.
The UHAS study points to a broader systemic issue where fungal infections are often overshadowed by the focus on bacterial resistance. Challenges such as limited access to fungal diagnostics and a lack of specialized medical mycology awareness hinder the effective management of these infections. Currently, many healthcare facilities in Ghana do not perform routine antifungal susceptibility testing, which often leads to the use of treatments that are increasingly ineffective against resistant strains.
To address this emerging threat, experts are calling for urgent improvements in laboratory capacity and the implementation of routine antifungal testing. Strengthening national surveillance to monitor resistance trends is also essential for informing treatment guidelines. By prioritizing diagnostic access and medical education on fungal pathogens, Ghana can better manage the risk of antifungal resistance and improve patient care outcomes across the country.